Why the study?
Does Thrombotest improve the stability of control of anticoagulant therapy compared to Quick's one-stage prothrombin time in patients receiving anticoagulants?
Does Thrombotest improve the stability of control of anticoagulant therapy compared to Quick's one-stage prothrombin time in patients receiving anticoagulants?
Answers are grounded in this paper and cite their sources.
Thrombotest provides technical simplicity and inter-laboratory comparability for monitoring anticoagulation, but does not improve stability of control compared to the Quick test.
The initial experience of using Thrombotest instead of Quick's one-stage prothrombin time to control anticoagulant therapy is described.Patients well controlled by the Quick test are often found to be over-anticoagulated by Thrombotest standards, so the introduction of Thrombotest has led to widespread reductions in dosage. No improvement in stability of control has been noted. The main advantages of Thrombotest seem to be its technical simplicity and the comparability of results obtained in different laboratories.
No takes yet. Share an insight, caveat, or question.
Miller et al. (1964) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: